Anti-TCRα/β antibodies
Synonyms: TCR a/b, IMD7, TCRA, TRAC, TRB
RECOMBINANT
Clone:
REA652
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Specifications for Anti-TCRα/β antibodies
Overview

REA652 recognizes the human α/β T cell receptor (TCR). The T cell receptor is a heterodimer composed of two transmembrane glycoprotein chains, α and β. In 95% of T cells the TCR consists of an α and β chain, whereas in 5% of T cells it has γ and δ chains. α and β chains are members of the Ig superfamily and consist of a constant and a polymorphic variable region. The variable region of the TCRα/β is involved in recognition of antigenic peptides presented by the MHC complex of antigen-presenting cells.

Additional information: Clone REA652 displays negligible binding to Fc receptors.

Alternative names

TCR a/b, IMD7, TCRA, TRAC, TRB

Detailed product information

Technical specifications

Clone
REA652
Isotype
recombinant human IgG1
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
TCRα/β
Distribution of antigen
T cells
Resources for Anti-TCRα/β antibodies
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for Anti-TCRα/β antibodies
Publications
  1. Brenner, M. B. et al. (1986) Identification of a putative second T-cell receptor. Nature 322 (6075): 145-149
  2. Oettgen, H. C. et al. (1984) Characterization of the two heavy chains of the T3 complex on the surface of human T lymphocytes. J. Biol. Chem. 259 (19): 12039-12048
  3. Call, M. E. et al. (2002) The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111 (7): 967-979
  4. Clinical and Laboratory Standards Institute (CLSI) (2007) Enumeration of immunologically defined cell populations by flow cytometry, CLSI document H42-A2 (ISBN 1-56238-640-9). CLSI Approved Guideline - Second Edition
  5. Clinical and Laboratory Standards Institute (CLSI) (2007) Clinical Flow Cytometric Analysis of Neoplastic Hematolympoid Cells, CLSI document H43-A2 (ISBN 1-56238-635-2). CLSI Approved Guideline - Second Edition
  6. van Dongen, J. J. M. et al. (2012) EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 26 (9): 1908-1975
  7. Rothe, G et al. (2012) Consensus protocol for the flow cytometric Immunophenotyping of hematopoietic malignancies. Leukemia 10 (5): 877-895
  8. Stelzer, G. T. et al. (1997) U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry 30 (5): 214-230

You have previously chosen International as your location.
What do you want to do?